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Objectives: Use of motor evoked potentials (MEP) and somatosensory evoked potentials (SSEP) monitoring during
thoracic and thoracoabdominal aortic surgery is controversial. This study evaluated the intraoperative use of SSEP and
MEP during thoracoabdominal repair and assessed their role in decreasing the risk of spinal cord ischemia and paralysis.
Methods:We conducted paired SSEP and MEP monitoring to assess agreement between the methods and their ability to
predict neurologic outcome in 233 patients. Changes in SSEP and MEP monitoring were classified as no change,
reversible change, or irreversible change during the intraoperative period and by the conclusion of surgery. Agreement
between the methods was computed using the Cohen  statistic. Sensitivity, specificity, and positive and negative
predictive values were computed for each method on the immediate and delayed neurologic deficit.
Results: Immediate neurologic deficit, determined immediately upon awakening from anesthesia and confirmed by a
neurologist, occurred in eight of 233 (3.4%) patients. For any change (reversible plus irreversible), agreement between
MEP and SSEP was relatively low (  0.53), despite being highly statistically significant (P < .001). MEP tended to
overestimate SSEP for immediate neurologic deficit, demonstrating a 53% false-positive rate, compared with a 33%
false-positive rate for SSEP (specificity ratio, 1.42; P< .0001). With irreversible change, agreement between the methods
was 90% (  0.896, P < .0001). Only irreversible change was significantly associated with neurologic outcome (odds
ratio, 21.9; P< .00001 for SSEP; 60.8, P< .0001 for MEP), but sensitivity and positive predictive values were low (37%
and 33% for SSEP; 22% and 45% for MEP, respectively). Reversible changes in neurophysiologic monitoring were not
significantly associated with immediate neurologic deficit. Negative predictive values for all negative evoked potential
findings were >98% for immediate deficit. No evoked potential variables were associated with delayed deficit.
Conclusions: SSEP and MEP monitoring were highly correlated only when intraoperative changes were irreversible.
Reversible changes were not significantly associated with immediate neurologic deficit. Irreversible changes were
significantly associated with immediate neurologic deficit, and the findings were identical for SSEP and MEP in this
variable, indicating that the more complex MEP measures do not add further information to that obtained from SSEP.
Normal SSEP and MEP findings had a strong negative predictive value, indicating that patients without signal loss are
unlikely to awake with neurologic deficit. ( J Vasc Surg 2009;49:36-41.)
Clinical Relevance: Monitoring of nerve activity during surgical procedures is vital to detect potential threats to
neurologic integrity and to allow quick action to prevent deficits. This study is relevant because it provides outcome data
comparing two ways to monitor evoked potentials during operations.Thoracoabdominal aneurysm repair has evolved during
the past 60 years. In the era of clamp and sew, paraplegia
remained a major concern, with rates as high as 31%.1
However, this rate has currently declined precipitously with
the use of adjuncts, including distal aortic perfusion, cere-
brospinal fluid (CSF) drainage, sequential clamping, and
reimplantation of intercostal arteries.2
Despite the improvement, paraplegia still remains a
concern. This has led to approaches in predicting neuro-
logic deficits (NDs) with the use of intraoperative neuro-
physiologic monitoring. In particular, cord function can be
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36assessed with motor evoked potentials (MEP) and somato-
sensory evoked potentials (SSEP) as performed routinely in
aortic surgery.3,4 This study aims at evaluating and com-
paring neurophysiologic monitoring using SSEP and MEP
during the repair of descending thoracic aortic (DTAA)
and thoracoabdominal aortic aneurysm repair (TAAA).
METHODS
Patients. The current study includes 233 patients
(190 men and 43 women) with a mean age of 67 years
(range, 18-87 years) who underwent DTAA (95) and
TAAA (138) repairs between December 2004 and April
2008. We previously reported 176 of these patients in our
series on the role of SSEP monitoring only.5 The 233
patients reported here underwent both SSEP and MEP
monitoring intraoperatively.
Patient characteristics and the aneurysm extent break-
down are summarized in Table I, with extent I comprising
29 patients (12.5%), extent II, 25 (10.7%); extent III, 22
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data were collected prospectively as approved by the Com-
mittee for the Protection of Human Subjects at The Uni-
versity of Texas Houston Medical School. We defined ND
as paraplegia or paraparesis upon awakening from the sur-
gical procedure.
Anesthesia. In order not to interfere with SSEP and
MEP monitoring, we have modified the anesthetic tech-
nique. Induction consists of front-end narcotic loading
with fentanyl citrate (15 g/kg), midazolam (0.05 mg/
kg), propofol (0.5 mg/kg), and cis-atracurium (0.2 mg/
kg). Patients are then maintained on a volatile agent (usu-
ally isoflurane) at 0.5 minimal alveolar concentration.
Neuromuscular blockade is maintained at one-quarter train
of four using supplemental doses of cis-atracurium. Hemo-
dynamics are managed with a combination of volume ad-
justments, -blockade, and dihydropyridines (nicardipine)
as required. No compromise of neuromotor or neurosen-
sory monitoring occurs with this approach.
At the end of the case, the patient is transitioned to a
Table I. Patient characteristics
Variable No. (%)
All patients 233 (100)
Age, y
65 59 (25.3)
65-70 60 (25.7)
71-76 57 (24.5)
76 57 (24.5)
Sex
Female 43 (19.0)
Male 190 (81.0)
COPD
Yes 103 (44.2)
No 130 (55.8)
Coronary artery disease
Yes 63 (27.0)
No 170 (73.0)
Aneurysm extent
I 29 (12.5)
II 25 (10.7)
III 22 (9.4)
IV 46 (19.7)
V 16 (6.9)
Descending 95 (40.8)
GFR, mL/min/1.73 m2
48 57 (24.5)
49-64 60 (25.7)
65-89 58 (24.9)
90 58 (24.9)
Cross-clamp time, min
35 63 (27.0)
35-50 56 (24.0)
51-64 58 (25.0)
65 56 (24.0)
Pump time, min
20 62 (26.6)
21-42 56 (24.0)
43-63 56 (24.0)
64 59 (25.4)
COPD, Chronic obstructive pulmonary disease; GFR, glomerular filtration
rate.low-dose dexmedetomidine infusion (0.1-0.2 g/kg/h)to maintain hemodynamic stability and provide sedative
and analgesic control. It is important not to use the recom-
mended loading dose of dexmedetomidine, because this is
associated with profound bradycardia and hypotension.
Minimal sedation is used because sedation makes identifi-
cation of postoperative NDs difficult, and we know that
early intervention is key to reversing delayed deficit.
Surgical technique. The details of our surgical tech-
nique have been described previously 2,6,7 and are briefly
reviewed here. A thoracoabdominal incision is made ex-
tending towards the shoulder blade following the curve of
the rib. The extent of the thoracoabdominal incision de-
pends on extent of the aneurysm. The patient is then
anticoagulated with heparin (1 mg/kg), followed by can-
nulation of the left lower pulmonary vein. This is attached
to the centrifugal pump with an online heat exchanger, and
the femoral artery is used to establish arterial inflow. The
proximal descending thoracic aorta is isolated and lifted off
the esophagus. We clamp sequentially starting at the mid-
dle descending thoracic aorta.
We suture an appropriately sized Dacron collagen or
gelatin impregnated woven graft using 2-0 or 3-0 polypro-
pylene suture in a running fashion. The distal clamp is then
placed above the celiac axis, if possible, and the remainder of
the thoracic aorta is opened. The lower intercostal arteries (8,
9, 10, 11, and 12) are identified, and if any are patent, a
sidehole is created in the graft to reimplant the thoracic aorta
containing the intercostal orifices to the graft. On rare occa-
sions, we bypass to the individual intercostals arteries.
After this, the arterial pulsatile flow is restored to the
implanted intercostal arteries. The graft is then passed into the
aortic hiatus and into the abdominal cavity. If feasible, we
clamp the infrarenal aorta or the iliac or the common femoral
artery. The celiac, superior mesenteric, and the right and left
renal arteries are inspected, and if atheromatous debris is
present, endarterectomy is performed to that area.We perfuse
and cool the celiac and superior mesenteric arteries with tepid
blood and the renal arteries with special cold crystalloid solu-
tion to keep the kidney temperature 20°C. A sidehole is
made opposite the visceral vessels and anastomosed to the
graft using a 2-0 polypropylene suture. Once the anastomosis
is completed, the patient is placed in head-down position, the
aorta is flushed of all air and debris, and pulsatile flow is
allowed into the visceral arteries.
Once the patient’s nasopharyngeal temperature reaches
36°C, the patient is weaned from the distal aortic perfu-
sion and all cannulae are removed. The patient is moved to
the intensive care unit, where the neurologic status is
monitored closely, keeping the CSF pressure 10 mm Hg
for 3 days. When the patient is stable, extubated, and is able
to move his or her extremities, the CSF catheter is removed
on the third postoperative day. It is important to keep the
mean arterial pressure under control and80 mmHg, and
we like to keep the CSF drainage 10 mm Hg, and the
hemoglobin level 10 mg/dL.
SSEP and MEP monitoring. A team led by a neurol-
ogist/neurophysiologist performed neurophysiologic moni-
toring. Eight-channel electroencephalogram monitoring was
tenti
tentia
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(Nicolet, Madison, Wis). Evoked potentials were performed
with the additional use of a Digitimer generator stimulator
(Digitimer, Hertfordshire, United Kingdom) for the motor
Fig 1. Sensory evoked po
Fig 2. Motor evoked poevoked potentials (Figs 1 and 2).For SSEP monitoring, stimulatory electrodes were
placed bilaterally at the level of the malleolus. Recording
electrodes were bilaterally placed at three levels: the popli-
teal fossa, cervical spine (C5), and vertex. The right and left
al monitoring procedure.
l monitoring procedure.posterior tibial nerves were stimulated at the ankle to obtain
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continuously throughout the operation. The SSEP were
bilaterally recorded at the three levels mentioned. A base-
line SSEP tracing was obtained before the start of the
operation. All subsequent tracing was superimposed and
compared with this baseline. The traditional 10/50 rule
was considered to define SSEP abnormalities. This is de-
fined as a 10% change in latency or 50% change in ampli-
tude. The evaluation of these three channels allowed us to
distinguish SSEP changes related to spinal cord injury from
peripheral nerve ischemia or cerebral injury.
ForMEPmonitoring, electrodes were placed at C3 and
C4 as defined by the international 10-20 system stimulat-
ing the precentral gyrus. The stimulus consisted of train of
five, an interstimulus interval of 2 milliseconds, and voltage
as high as 400 V. Myogenic responses were recorded bilat-
erally with needle electrodes placed in the abductor digiti
minimi, tibialis anterior, and abductor hallucis muscles.
Compound muscle action potentials were checked inter-
mittently throughout the operation and were considered
on an all-or-none basis, present or absent.
Intraoperative corrective measures. During the op-
eration, a series of corrective measures are instituted if SSEP
or MEP findings show any signs of spinal cord dysfunction.
These include increasing the mean central pressure to 80
mm Hg and increasing distal aortic pressure to 60 mm
Hg. The anesthesia team will also lower the CSF pressure
by free drainage and increase hemoglobin levels by transfu-
sion. Furthermore, additional patent intercostal arteries are
reimplanted, including T4 to T7 and L1. If the change
occurs while the intercostal arteries are being implanted,
the anastomosis is completed expeditiously to restore pul-
satile flow to the intercostal arteries.
Statistical methods. Evoked potential measures were
coded as permanent, transient, or any (permanent or tran-
sient) change. Permanent change was defined as absence of
signal by the conclusion of surgery. Agreement between
the methods (SSEP vs MEP) was estimated using the
Cohen  statistic. Screening test calculations (sensitivity,
specificity, positive and negative predictive values, false-
positive and false-negative rates) were performed using
standard contingency table methods. Comparisons of
screening test performance were computed using the Gart
and Nam score with skewness correction. Associations be-
tween risk factors and outcome, and risk factors and SSEP
changes were computed by contingency table methods
using exact statistics. Computations were performed using
SAS 9.1.3 software (SAS Institute, Cary, NC). Those not
available in SAS were computed using locally produced
programs, except the Gart and Nam score, which was
computed using NCSS (Number Cruncher Statistical Sys-
tems, Kaysville, Utah).
RESULTS
The ND rate in our series of patients was 3.4% (8 of
233). Neurologic deficit rate by extent is presented in Table
II. Nine of 233 patients had permanent changes in SSEP,
but only three (33%) exhibited NDs upon awakening. Theother five of eight total patients with NDs did not have
permanent SSEP changes. Similarly, for motor changes, 11
(4.7%) had permanent MEP defects, but only five (45%)
went on to develop ND. The remaining three patients who
sustained a ND did not have permanent MEP changes.
Sensitivity for permanent SSEP and MEP changes was
poor, at 37.5% and 62.5%, although specificity and negative
predictive values were 97% for both evoked potential
tests, with 2.2% and 1.4% deficit rates among patients with
negative permanent changes in SSEP and MEP tracings,
respectively. Agreement between SSEP and MEP perma-
nent change findings was 89.6% by  statistic (P  .0001).
Transient changes were not predictive of ND. For
SSEP, three of the eight patients who were found to have
NDs had transient changes. None of the MEP transient
patients had NDs. Among the SSEP transient group, these
three deficits represented 4% (3 of 68) of the exposed,
which was not different from the overall 3.5% rate. That is,
transient SSEP loss did not discriminate for ND risk.
For “any” change (reversible plus irreversible), sensitiv-
ity was improved but specificity worsened considerably. For
SSEP, sensitivity increased to 75%, but specificity fell to
67%. Similarly for MEP “any” change, sensitivity was 88%
but specificity was only 47%. The worsening of specificity
with “any” change caused the specificities of the two meth-
ods to separate statistically (specificity ratio, 1.42; P 
.0001), but this was not true for the improvement in
sensitivity. Agreement for betweenMEP “any” change and
SSEP “any” change was low (  0.53) despite being
statistically significant (P  .001). MEP tended to overes-
timate deficits relative to SSEP for this measure, demon-
strating a 53% false-positive rate compared with a 33%
false-positive rate for SSEP (P  .0001).
Only irreversible change was significantly associated
with neurologic outcome, with odds ratios of 21.9 (P 
.00001) for SSEP and 60.8 (P  .0001) for MEP. Revers-
ible changes were not significantly associated with immedi-
ate ND. Negative predictive values for all negative evoked
potential findings were 98% for immediate deficit. No
evoked potential variables were associated with delayed
deficit.
DISCUSSION
In our current practice, the use of MEP and SSEP
monitoring has become a standard part of intraoperative
patient monitoring. This had led to our anesthesia team
diligently modifying anesthetic agents to prevent interfer-
Table II. Neurologic deficit by aneurysm extent
Aneurysm extent
I II III IV V Descending
Patients, No. 2 2 1 2 1 1
Neurologic deficit, % 6.9 8.0 4.55 4.35 0.0 1.05ence with the neurophysiologic monitoring.
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DTAA and TAAA for its reliability in ruling out spinal
dysfunction.5 Thus the question arises: What is the role of
additional neurophysiologic monitoring with intraopera-
tive MEP measurements? Many studies have shown the
reliability of MEP monitoring in predicting postopera-
tive ND.3,4,8
In this series of 233 patients, NDs developed in eight.
Analysis of the SSEPmonitoring revealed nine patients who
had permanent change, of which NDs developed in only
three. The remaining five patients with NDs did not have
SSEP changes at the end of the operation. The sensitivity
for this cohort of patients was low, at 37.5%; however, the
specificity and negative predictive value remained high,
indicating that patients with no permanent SSEP change at
the end of the case had 97% probability of waking up
without ND.
For MEP monitoring, 11 patients had permanent
change but only five had immediate postoperative NDs.
The remaining three patients with NDs did not have per-
manent change on MEP monitoring. Although the sensi-
tivity increased with this monitoring, this was not statisti-
cally significant compared with SSEP monitoring. The
specificity and negative predictive value remained compa-
rable with SSEP, with a value 97%.
If we combined all changes intraoperatively (transient
and permanent change), the sensitivity for both SSEP and
MEP increase; however, this is at the cost of detectingmore
false-positives. Thus, the specificity of the test declined in
order to detect more patients with a ND at the end of the
case.
Neurophysiologic monitoring has allowed us to per-
form corrective measures when there is a change in signal.
These include increasing central mean arterial pressure to
80 mm Hg, increasing distal aortic pressure to 60 mm
Hg, decreasing CSF pressure by keeping the drain open,
establishing pulsatile flow, and reattaching additional
patent intercostals arteries (ie, T4 to T7 and L1). Despite
our continuing effort to prevent NDs, the rate still remains
at 3.4% in this series. Additional monitoring with MEP has
not added any further benefit intraoperatively to help de-
tect and perhaps change the likely course of NDs postop-
eratively. Whether we use SSEP orMEP, if there is a change
during the operation, it is difficult to predict which patients
will have NDs. However, we are able to predict with very
high probability that if there is no change at the end of the
case, the patient will wake up neurologically intact.
We retrospectively analyzed the prospectively collected
MEP and SSEP data, thus setting up limitations to the
study. Furthermore, this is not a randomized study in that
we treated all neurophysiologic signal changes. Thus, the
study did not include a group of patients where we decided
not to treat with the corrective measures stated earlier when
there was a signal change. This would be ethically impossi-
ble in our opinion as surgeons, when we know a portion of
these patients upon awakening will have NDs and hence we
have potentially altered ND in the remainder of these
patients.Although it might seem reasonable for us to perform
extraordinary adjunctive maneuvers by increasing the distal
perfusion pressures and implanting all intercostal arteries in
all patients regardless of monitoring status, it may not be
wise to do so. Increased distal pressure may come at the
expense of adequate proximal perfusion pressure, and im-
planting all intercostal arteries may increase the operative
time and bleeding risk. In almost all patients who demon-
strate no changes in neurophysiologic monitoring, our
standard protective measures are clearly adequate. In pa-
tients who do have changes, however, we believe that the
additional margin of safety provided by further maneuvers
justifies any increased risk associated with performing them.
It appears that sample sizes are required in these studies
to be able to deduce whether permanent MEP change or
SSEP change correlates with an immediate ND. The work
of Jacobs et al3 has been used to show that MEP monitor-
ing is a highly reliable tool to assess spinal cord function,
such that patients who wake up with permanent loss of
MEP had NDs and those with transient change had no
immediate deficits.3 At this moment, the latter appears to
be relatively comparable in our series, although the same
information has been achieved by SSEP monitoring. This
does not seem to apply in our series of 233 patients.
CONCLUSION
The role of neurophysiologic monitoring for DTAA and
TAAA repair has continued to remain controversial. We have
shown that SSEP monitoring is a reliable tool in ruling out
ND. However, the addition of MEP monitoring has not
contributed additional information in predicting ND.
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RECOUP THE LOUPES 
Despite extremely limited resources, surgeons in developing countries work to provide their 
patients with the best possible care. For many of these surgeons, technology such as loupes, 
which facilitate delicate procedures, is simply out of reach.  
One year ago, Loupes Around The World distributed its first pair of loupes to a plastic surgeon
in Phnom Penh, Cambodia. Before Loupes Around The World, this surgeon commonly 
repaired cleft lips and palates, and treated trauma patients with maxillofacial injuries without 
the benefit of surgical magnification. Since then, this not-for-profit organization has provided 
loupes to surgeons from Panama to India and continues to receive requests from surgeons 
around the world.  
Loupes Around The World is now recycling donated loupes via a program called “Recoup the 
Loupes.” Surgeons with unused loupes are asked to send them to the foundation; there, repairs 
can be made to adjustable loupes, and the telescopes from fixed loupes can be installed into 
new lenses and frames. For fixed loupes, optical measurements are taken to ensure that the 
loupes will meet the needs of each individual surgeon. 
Please send your unused loupes to:  
David C. Knight, M.D., F.A.C.S. 
Loupes Around The World 
c/o Surgical Associates of Waterbury 
1211 West Main St. 
Waterbury, CT 06708 
Loupes Around The World accepts loupes made by any manufacturer. For more information 
about Loupes Around The World, as well as information about how to contribute, please visit: 
www.loupesaroundtheworld.org. Upon receiving loupes, a letter of acknowledgment will be 
sent to the donor for tax purposes. Loupes Around the World is a 501(c)3 tax-exempt 
organization.  
